Assistant Professor, Medicine, UCLA School of Medicine
Gastroenterology
Dr. Gil Y. Melmed, MD
|
|
Give Review
Melmed works in the field of Gastroenterology. He graduated from Albert Einstein College of Medicine of Yeshiva University. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Melmed is a published doctor and has 68 publications published. The lastest was: 'Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulc...' Melmed accepts Medicare.
Publications
- Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulc...
- Implementing quality measures for inflammatory bowel Disease.
- Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.
- Development and validation of a Disease-targeted quality of life instrument for chronic diverticular Disease: the DV-QOL.
- Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel Disease.
- Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales.
- Weeding out the facts: the reality about cannabis and Crohn's Disease.
- GERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients.
- Construct validity of the Patient Reported Outcomes Measurement Information System (PROMIS®) gastrointestinal symptom scales in Systemic sclerosis.
- Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel Disease patients.
- Significant Variation in Recommendation of Care for Women of Reproductive Age with Ulcerative Colitis Postileal Pouch-Anal Anastomosis.
- Vaccinations in older adults with gastrointestinal Diseases.
- Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database.
- Translating improved quality of care into an improved quality of life for patients with inflammatory bowel Disease.
- Quality improvement in inflammatory bowel Disease.
- Assessing health status in inflammatory bowel Disease using a novel single-item numeric rating scale.
- Quality Indicators for Inflammatory Bowel Disease: Development of Process and Outcome Measures.
- Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major Colorectal surgery: A pilot study.
- Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's Disease?
- Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's Disease.
- Facial Ulceration in a Patient With Crohn's Disease.
- Vaccinations while on thiopurines: some protection is better than none.
- Are immunosuppressive medications associated with decreased responses to routine immunizations? A Systematic review.
- Immunizations and IBD: Whose responsibility is it? If I'm the prescribing doctor, shouldn't it be mine?
- Variants in ZNF365 isoform D are associated with Crohn's Disease.
- Genetic predictors of medically refractory Ulcerative colitis.
- The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's Disease: one size does not fit all.
- A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis.
- New clinical method for distinguishing D-IBS from other gastroIntestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
- Improving quality of care in IBD: a STEEEP challenge.
- Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel Disease.
- Vaccination strategies for patients with inflammatory bowel Disease on immunomodulators and biologics.
- A new method for endoscopic closure of gastrocolonic fistula: novel application of a cardiac septal defect closure device (with video).
- A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel Disease-unclassified and indeterminate colitis.
- Clarithromycin for Crohn's: A flash in the pan?
- Controversies in Ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.
- Vaccinations and the Utilization of Immunosuppressive IBD Therapy.
- Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.
- Proximal small Intestinal CD detected by CE.
- Anti-aging therapy with human growth hormone associated with metastatic colon Cancer in a patient with Crohn's colitis.
- The impact of medical therapy for inflammatory bowel Disease on pregnancy outcome.
- Family history and serology predict Crohn's Disease after ileal pouch-anal anastomosis for ulcerative colitis.
- Predicting a change in diagnosis from ulcerative colitis to Crohn's Disease: a nested, case-control study.
- NOD2 variants and antibody response to microbial antigens in Crohn's Disease patients and their unaffected relatives.
- Patients with inflammatory bowel Disease are at risk for vaccine-preventable illnesses.
- Capsule endoscopy: practical applications.
- New insights into the pathogenesis of inflammatory bowel Disease.
- Risk of Upper GastroIntestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NS...
- Quality of life at the end of life: trends in patients with metastatic prostate Cancer.
- Life after radical prostatectomy: a longitudinal study.
- Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chr...
- Consequences of frequent nocturnal gastro-oesophageal reflux Disease among employed adults: symptom severity, quality of life and work productivity.
- Biomarkers and health-related quality of life in end-stage renal disease: a Systematic review.
- Certolizumab pegol.
- Genome-wide association identifies multiple Ulcerative colitis susceptibility loci.
- Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis.
- Future biologic targets for IBD: potentials and pitfalls.
- Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's Disease.
- Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel Disease unclassified does not predict outcome after ileal pouch-ana...
- Evaluating breath methane as a diagnostic test for constipation-predominant IBS.
- Human Intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
- Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn''s Disease.
- Are high-dose perioperative steroids necessary in patients undergoing Colorectal surgery treated with steroid therapy within the past 12 months?
- Phantom publications among applicants to a Colorectal surgery residency program.
- Predicting response to Anti-TNF Agents for the treatment of crohn''s Disease.
- Comparison of adenoma detection rates between gastroenterologists and Colorectal surgeons.
- Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.
Schools
Albert Einstein College of Medicine of Yeshiva University
Cedars Sinai Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
UCLA Medical Center -
Cedars-Sinai Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1336102524 | |
| NPPES Provider LastName | MELMED | |
| NPPES Provider FirstName | GIL | |
| NPPES Provider ZIPCode | 900486101 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 354.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336102524 |
| Last Name Of The Provider | MELMED |
| First Name Of The Provider | GIL |
| View All |
Similar Doctors
|
Dr. Claudia P. Sanmiguel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin A. Ghassemi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siamak Tabib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin Derezin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Teller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hartley C. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas A. Gardner, MD |
|
|
Dr. Neil Kaplowitz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|